The results showed that the antibody of METTL16 enriched the FBXO5 mRNA (Fig. 3F) and MAT2A mRNA (Supplementary Fig. 1) in BC cells, indicated the binding relationship between METTL16 and FBXO5 mRNA. The gene discussed is METTL16; the disease is breast cancer.